Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds Italy recommending AstraZeneca only for over-60s)AMSTERDAM, April 7 (Reuters) - European countries should make their own decisions about how to handle the risk of rare blood clots from AstraZeneca's COVID-19 vaccine, based on prevailing infe...
Read more(Recasts and adds detail throughout)AMSTERDAM, April 7 (Reuters) - European countries should make their own decisions about how to handle the risk of rare blood clots from AstraZeneca's COVID-19 vaccine, based on prevailing infection rates and the...
Read more(Adding detail)AMSTERDAM, April 7 (Reuters) - The European drug regulator has received reports of 169 cases of a rare brain blood clot in people who received AstraZeneca's COVID-19 vaccine, a official said on Wednesday, as the agency continued to ...
Read moreLONDON, April 7 (Reuters) - Blood clot side effects from the AstraZeneca COVID-19 vaccine are serious but vanishingly rare, England's deputy Chief Medical Officer Jonathan Van-Tam said on Wednesday."My final cautionary point for you is that this i...
Read moreLONDON, April 7 (Reuters) - British health officials said they did not know for sure that blood clot risks were directly associated with only one COVID-19 vaccine."This is an extremely rare adverse event, we do not know for sure that it's related ...
Read moreBERLIN, April 7 (Reuters) - Germany's vaccine advisory committee sees no disadvantages or risks from giving younger recipients of AstraZeneca's COVID-19 vaccine a second dose of an alternative shot, two of its members said on Wednesday."Nobody ex...
Read moreBERLIN, April 7 (Reuters) - Instances of rare clotting in people who got AstraZeneca's COVID-19 vaccine were 20 times higher than would be likely in the same time period among a specific age group, Christian Bogdan, a member of Germany's vaccine ...
Read more(adds details from letter, context)BRUSSELS, April 7 (Reuters) - European Union health ministers have been told that new regulatory guidance for AstraZeneca's COVID-19 vaccine is expected to have an immediate impact on inoculation plans and would ...
Read more* UK says 18-29 year olds should get other shots where possible* Oxford/AZ shot associated with rare cases of brain blood clots* Benefits outweigh the risks for vast majority, regulator says (Recasts headline and lead)By Guy Faulconbridge, Kate H...
Read more(Adds details on Europe's regulator, pace of rollout)LONDON, April 7 (Reuters) - Britain should not give Oxford/AstraZeneca's COVID-19 vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on We...
Read more(Recasts, adds detail)LONDON, April 7 (Reuters) - Britain should not give Oxford University/AstraZeneca's vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare s...
Read more* UK says 18-29 year olds should get other shots where possible* Oxford/AZ shot associated with rare cases of brain blood clots* Benefits outweigh the risks for vast majority, regulator says (Adds PM Johnson's reaction)By Guy Faulconbridge, Kate ...
Read moreLONDON, April 7 (Reuters) - Britain's recommendation against giving the Oxford-AstraZeneca COVID-19 vaccine to those aged under 30 due to the risk of blood clots will have a negligible impact on the vaccine programme, England's deputy chief medic...
Read more
TOP NEWS: AstraZeneca jab benefits outweigh risks of side effects
Read moreLONDON, April 7 (Reuters) - People in Britain who have received their first dose of the AstraZeneca COVID-19 vaccine should continue to be offered their second dose, despite a change in guidance over administering the shot to younger citizens, he...
Read more
Last checked at